Company news
Oric Pharmaceuticals, Inc. news in 2024
Oric Pharmaceuticals, Inc.'s news releases, calls and decks from 2024, newest first.
ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
November 11, 2024
ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 31, 2024
ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 22, 2024
ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 8, 2024
OpenBench and ORIC Pharmaceuticals Launch Success-Driven Discovery Collaboration
September 16, 2024
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
August 25, 2024
ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates
August 11, 2024
ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs
August 4, 2024
ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
July 15, 2024
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
May 5, 2024
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
April 14, 2024
ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
April 7, 2024
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
March 10, 2024
ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
March 5, 2024
ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 4, 2024
ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
February 13, 2024
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
January 21, 2024
ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones
January 7, 2024
ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 1, 2024
Decks in 2024
- Investor Presentation (January 2024)
Investor deck · 43 slides · Jan 9, 2024